Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Receivables - Net (2016 - 2025)

Bio-Techne has reported Receivables - Net over the past 16 years, most recently at $184.6 million for Q4 2025.

  • Quarterly results put Receivables - Net at $184.6 million for Q4 2025, down 15.29% from a year ago — trailing twelve months through Dec 2025 was $184.6 million (down 15.29% YoY), and the annual figure for FY2025 was $206.9 million, down 14.3%.
  • Receivables - Net for Q4 2025 was $184.6 million at Bio-Techne, roughly flat from $183.9 million in the prior quarter.
  • Over the last five years, Receivables - Net for TECH hit a ceiling of $241.4 million in Q2 2024 and a floor of $145.4 million in Q2 2021.
  • Median Receivables - Net over the past 5 years was $203.3 million (2022), compared with a mean of $196.5 million.
  • Biggest five-year swings in Receivables - Net: surged 34.34% in 2021 and later fell 17.79% in 2025.
  • Bio-Techne's Receivables - Net stood at $152.9 million in 2021, then increased by 20.84% to $184.8 million in 2022, then increased by 12.28% to $207.5 million in 2023, then grew by 5.06% to $217.9 million in 2024, then decreased by 15.29% to $184.6 million in 2025.
  • The last three reported values for Receivables - Net were $184.6 million (Q4 2025), $183.9 million (Q3 2025), and $206.9 million (Q2 2025) per Business Quant data.